— Know what they know.
Not Investment Advice
Also trades as: SUVENPHAR.NS (NSE) · $vol 3M

SUVENPHAR.BO BSE

Suven Pharmaceuticals Limited
1W: +0.3% 1M: -4.4% 3M: -13.6% 1Y: +61.1% 3Y: +71.2% 5Y: +626.3%
₹1,075.30
Last traded 2025-06-10 — delisted
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹411.4B mcap · 152M float · 0.0048% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 67 Grade A
Profitability
52
Balance Sheet
85
Earnings Quality
63
Growth
60
Value
37
Momentum
86
Safety
100
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SUVENPHAR.BO scores highest in Safety (100/100) and lowest in Value (37/100). An overall grade of A places SUVENPHAR.BO among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.27
Safe Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-0.55
Possible Manipulator
Ohlson O-Score
-10.56
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 91.3/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 2.00x
Accruals: -6.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SUVENPHAR.BO scores 10.27, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SUVENPHAR.BO scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SUVENPHAR.BO's score of -0.55 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SUVENPHAR.BO's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SUVENPHAR.BO receives an estimated rating of AA+ (score: 91.3/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SUVENPHAR.BO's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
91.13x
PEG
-12.97x
P/S
39.13x
P/B
13.35x
P/FCF
82.66x
P/OCF
52.51x
EV/EBITDA
60.59x
EV/Revenue
14.35x
EV/EBIT
77.96x
EV/FCF
82.82x
Earnings Yield
0.95%
FCF Yield
1.21%
Shareholder Yield
0.00%
Graham Number
$179.65
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 91.1x earnings, SUVENPHAR.BO is priced for high growth expectations. Graham's intrinsic value formula yields $179.65 per share, 499% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.805
NI / EBT
×
Interest Burden
0.922
EBT / EBIT
×
EBIT Margin
0.184
EBIT / Rev
×
Asset Turnover
0.449
Rev / Assets
×
Equity Multiplier
1.400
Assets / Equity
=
ROE
8.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SUVENPHAR.BO's ROE of 8.6% is driven by Asset Turnover (0.449), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
1.87%
Fair P/E
12.25x
Intrinsic Value
$118.68
Price/Value
8.56x
Margin of Safety
-755.83%
Premium
755.83%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SUVENPHAR.BO's realized 1.9% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SUVENPHAR.BO trades at a 756% premium to its adjusted intrinsic value of $118.68, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 12.2x compares to the current market P/E of 91.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1283 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1015.70
Median 1Y
$1340.89
5th Pctile
$711.63
95th Pctile
$2540.00
Ann. Volatility
39.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 35.0% 35.8% 37.1% 33.7% 37.6% 33.5% 33.7% 30.2% 26.5% 25.2% 26.0% 25.1% 21.3% 15.9% 12.7% 12.4% 14.1% 14.3% 13.7% 8.6% 8.60%
ROA 26.8% 27.4% 28.4% 26.8% 29.9% 27.5% 27.6% 24.9% 21.9% 21.7% 22.4% 22.0% 19.2% 14.2% 11.4% 10.5% 12.2% 10.1% 9.7% 6.1% 6.14%
ROIC 28.8% 28.1% 28.2% 26.4% 27.7% 33.5% 35.0% 31.6% 30.8% 30.9% 31.9% 33.6% 29.1% 21.9% 18.5% 17.2% 24.4% 21.5% 29.6% 12.6% 12.62%
ROCE 42.0% 37.8% 39.0% 36.6% 43.0% 41.6% 42.6% 41.1% 35.2% 31.3% 32.1% 29.2% 25.1% 19.1% 14.5% 13.6% 14.9% 12.8% 12.8% 6.8% 6.76%
Gross Margin 63.0% 47.5% 56.2% 54.7% 57.7% 58.8% 58.9% 52.5% 55.6% 57.5% 61.6% 62.4% 52.2% 30.1% 35.1% 79.8% 81.9% 49.1% 73.0% 74.6% 74.60%
Operating Margin 47.1% 37.5% 40.0% 37.4% 44.8% 44.4% 41.1% 35.5% 41.7% 45.6% 44.4% 45.8% 30.4% 22.2% 40.9% 33.8% 61.3% 25.3% 48.8% 13.8% 13.85%
Net Margin 41.3% 36.2% 39.8% 32.2% 40.9% 27.5% 31.7% 25.9% 30.4% 33.6% 34.7% 34.4% 21.3% 21.1% 26.3% 31.8% 27.0% 10.4% 8.9% 13.3% 13.33%
EBITDA Margin 52.0% 42.3% 45.6% 42.1% 64.0% 52.2% 47.8% 39.8% 45.1% 48.9% 51.1% 51.0% 36.2% 35.7% 34.6% 45.8% 35.9% 24.0% 15.7% 24.6% 24.58%
FCF Margin 34.8% 31.2% 29.3% 26.5% 23.0% 20.8% 19.3% 16.4% 13.5% 10.2% 7.2% 7.5% 8.4% 14.4% 21.7% 26.6% 29.3% 22.0% 14.5% 17.3% 17.33%
OCF Margin 45.8% 41.6% 39.8% 36.6% 32.3% 28.7% 26.1% 21.2% 16.4% 11.6% 7.2% 7.5% 8.4% 15.6% 24.5% 30.6% 34.2% 28.5% 21.3% 27.3% 27.28%
ROE 3Y Avg snapshot only 13.71%
ROE 5Y Avg snapshot only 19.84%
ROA 3Y Avg snapshot only 11.51%
ROIC 3Y Avg snapshot only 14.54%
ROIC Economic snapshot only 11.52%
Cash ROA snapshot only 8.89%
Cash ROIC snapshot only 12.90%
CROIC snapshot only 8.19%
NOPAT Margin snapshot only 26.69%
Pretax Margin snapshot only 16.97%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.12%
SBC / Revenue snapshot only 0.77%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 32.11 34.41 32.08 33.53 27.84 34.25 25.49 26.56 33.23 29.26 29.12 33.09 50.04 57.36 84.99 123.38 104.48 114.50 152.85 104.84 91.127
P/S Ratio 12.49 12.72 11.99 12.51 10.45 12.05 8.52 8.53 9.65 8.98 9.16 10.98 15.89 16.38 21.87 31.18 27.80 25.59 25.78 14.32 39.128
P/B Ratio 11.24 10.56 10.21 9.85 9.13 10.18 7.61 7.62 8.38 6.93 7.12 7.38 9.37 8.40 9.97 15.15 14.73 18.06 23.04 6.86 13.349
P/FCF 35.85 40.80 40.94 47.15 45.48 57.96 44.10 52.16 71.58 88.38 126.68 146.92 188.81 114.03 100.85 117.27 95.04 116.46 178.04 82.66 82.665
P/OCF 27.28 30.57 30.17 34.15 32.33 41.99 32.60 40.20 58.97 77.66 126.68 146.92 188.81 105.03 89.43 101.80 81.31 89.89 120.91 52.51 52.510
EV/EBITDA 24.81 27.20 26.16 27.24 20.67 22.50 15.70 15.97 20.24 18.95 18.99 21.44 32.12 35.39 53.54 79.72 71.51 75.66 95.04 60.59 60.593
EV/Revenue 12.56 12.68 11.95 12.41 10.37 11.72 8.21 8.30 9.41 8.67 8.85 10.47 15.28 15.66 21.06 30.52 27.20 25.58 25.78 14.35 14.350
EV/EBIT 24.66 26.16 24.55 25.28 19.97 22.43 16.25 17.05 21.91 20.55 20.59 23.22 35.24 40.08 63.01 95.36 84.32 89.52 114.09 77.96 77.963
EV/FCF 36.06 40.66 40.79 46.80 45.11 56.36 42.47 50.70 69.75 85.31 122.41 140.11 181.50 109.03 97.12 114.79 92.98 116.41 177.99 82.82 82.817
Earnings Yield 3.1% 2.9% 3.1% 3.0% 3.6% 2.9% 3.9% 3.8% 3.0% 3.4% 3.4% 3.0% 2.0% 1.7% 1.2% 0.8% 1.0% 0.9% 0.7% 1.0% 0.95%
FCF Yield 2.8% 2.5% 2.4% 2.1% 2.2% 1.7% 2.3% 1.9% 1.4% 1.1% 0.8% 0.7% 0.5% 0.9% 1.0% 0.9% 1.1% 0.9% 0.6% 1.2% 1.21%
Price/Tangible Book snapshot only 10.674
EV/OCF snapshot only 52.606
EV/Gross Profit snapshot only 20.583
Acquirers Multiple snapshot only 41.004
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $179.65
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.21 2.57 2.57 3.19 3.19 5.36 5.36 4.26 4.26 6.37 6.37 10.40 26.98 11.82 11.82 4.90 4.90 2.43 2.43 2.92 2.923
Quick Ratio 1.30 1.66 1.66 2.03 2.03 4.02 4.02 2.79 2.79 4.40 4.40 7.99 20.95 9.65 9.65 4.00 4.00 1.98 1.98 1.98 1.984
Debt/Equity 0.15 0.12 0.12 0.10 0.10 0.06 0.06 0.06 0.06 0.04 0.04 0.03 0.02 0.03 0.03 0.02 0.02 0.16 0.16 0.12 0.119
Net Debt/Equity 0.07 -0.04 -0.04 -0.07 -0.07 -0.28 -0.28 -0.21 -0.21 -0.24 -0.24 -0.34 -0.36 -0.37 -0.37 -0.32 -0.32 -0.01 -0.01 0.01 0.013
Debt/Assets 0.12 0.10 0.10 0.08 0.08 0.05 0.05 0.05 0.05 0.04 0.04 0.02 0.02 0.03 0.03 0.02 0.02 0.09 0.09 0.08 0.081
Debt/EBITDA 0.33 0.31 0.31 0.27 0.22 0.14 0.14 0.13 0.15 0.11 0.11 0.08 0.06 0.14 0.18 0.11 0.10 0.69 0.68 1.05 1.049
Net Debt/EBITDA 0.14 -0.10 -0.10 -0.20 -0.17 -0.64 -0.60 -0.46 -0.53 -0.68 -0.66 -1.04 -1.29 -1.62 -2.06 -1.72 -1.59 -0.03 -0.03 0.11 0.112
Interest Coverage 34.89 51.62 60.27 87.03 152.33 109.34 125.57 141.71 106.73 103.96 113.00 109.91 96.86 75.59 53.03 43.59 37.09 27.71 31.86 18.72 18.716
Equity Multiplier 1.31 1.25 1.25 1.22 1.22 1.20 1.20 1.20 1.20 1.13 1.13 1.10 1.04 1.10 1.10 1.27 1.27 1.79 1.79 1.47 1.470
Cash Ratio snapshot only 0.638
Debt Service Coverage snapshot only 24.082
Cash to Debt snapshot only 0.894
FCF to Debt snapshot only 0.697
Defensive Interval snapshot only 583.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.69 0.74 0.76 0.72 0.80 0.78 0.83 0.77 0.75 0.71 0.71 0.66 0.60 0.50 0.44 0.42 0.46 0.45 0.57 0.45 0.449
Inventory Turnover 1.87 2.24 2.35 2.05 2.33 2.29 2.39 1.97 1.94 1.96 1.94 1.81 1.69 1.85 1.91 1.99 1.85 2.32 2.31 1.36 1.359
Receivables Turnover 8.61 11.68 11.99 7.94 8.80 8.99 9.51 9.76 9.48 7.72 7.77 10.50 9.83 8.60 7.64 5.99 6.76 5.73 7.25 4.69 4.690
Payables Turnover 4.59 5.85 6.14 5.31 6.03 6.22 6.49 6.25 6.16 7.57 7.49 8.34 7.56 11.03 11.38 8.97 8.10 7.54 7.51 2.90 2.902
DSO 42 31 30 46 41 41 38 37 38 47 47 35 37 42 48 61 54 64 50 78 77.8 days
DIO 195 163 156 178 157 159 153 185 188 186 188 201 216 198 191 184 197 157 158 269 268.6 days
DPO 79 62 59 69 61 59 56 58 59 48 49 44 48 33 32 41 45 48 49 126 125.8 days
Cash Conversion Cycle 158 132 127 155 138 141 135 164 167 185 186 192 205 207 207 204 206 172 159 221 220.6 days
Fixed Asset Turnover snapshot only 0.856
Operating Cycle snapshot only 346.4 days
Cash Velocity snapshot only 4.503
Capital Intensity snapshot only 3.070
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — 5.2% 1.5% 68.8% 30.5% 31.6% 35.7% 25.5% 10.0% 3.9% -1.2% -3.0% -10.5% -21.6% -30.7% -26.2% -10.2% 13.9% 62.2% 88.7% 88.74%
Net Income — 3.9% 1.3% 66.3% 26.0% 25.2% 21.4% 8.2% -14.9% -9.4% -7.0% 0.1% -2.1% -27.0% -43.3% -43.8% -24.8% -10.9% 6.4% 2.0% 2.05%
EPS — 3.9% 1.3% 66.3% 26.1% 25.3% 21.2% 8.1% -14.9% -9.4% -6.9% 0.1% -2.1% -27.0% -43.3% -43.9% -25.4% -14.1% -29.7% 1.9% 1.87%
FCF — 2.9% 86.1% 19.5% -13.9% -12.2% -10.5% -22.6% -35.5% -49.2% -63.0% -55.7% -44.1% 10.9% 1.1% 1.6% 2.1% 74.2% 8.4% 23.0% 23.01%
EBITDA — 3.5% 1.1% 53.6% 29.3% 47.1% 55.3% 43.1% 1.9% -8.8% -11.9% -8.8% -8.4% -24.1% -41.5% -42.1% -28.2% -13.0% 11.9% 16.8% 16.76%
Op. Income — 4.8% 1.3% 62.7% 21.2% 31.7% 39.7% 29.5% 11.2% 2.3% -1.1% 2.6% -7.1% -30.9% -43.2% -47.2% -14.1% 23.1% 99.6% 1.1% 1.09%
OCF Growth snapshot only 68.10%
Asset Growth snapshot only 1.22%
Equity Growth snapshot only 91.46%
Debt Growth snapshot only 10.42%
Shares Change snapshot only 0.17%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — 1.0% 50.5% 27.1% 8.7% 2.4% -2.4% -3.5% -4.0% -2.4% 3.6% 10.6% 10.56%
Revenue 5Y — — — — — — — — — — — — — — — — — 50.0% 30.8% 23.4% 23.42%
EPS 3Y — — — — — — — — — 77.0% 36.8% 21.7% 1.6% -6.0% -13.8% -15.3% -14.7% -17.2% -28.1% -17.0% -16.99%
EPS 5Y — — — — — — — — — — — — — — — — — 28.3% 0.4% 0.6% 0.56%
Net Income 3Y — — — — — — — — — 77.0% 36.8% 21.7% 1.6% -6.1% -13.8% -15.2% -14.4% -16.1% -17.5% -16.9% -16.86%
Net Income 5Y — — — — — — — — — — — — — — — — — 29.3% 9.1% 0.7% 0.66%
EBITDA 3Y — — — — — — — — — 82.7% 42.3% 26.1% 6.5% 0.6% -7.1% -8.9% -12.5% -15.5% -16.8% -14.9% -14.91%
EBITDA 5Y — — — — — — — — — — — — — — — — — 32.1% 13.5% 6.3% 6.26%
Gross Profit 3Y — — — — — — — — — 1.0% 49.0% 27.9% 8.3% -0.6% -9.7% -7.1% -1.8% 0.0% 10.3% 18.1% 18.11%
Gross Profit 5Y — — — — — — — — — — — — — — — — — 52.6% 35.4% 28.1% 28.11%
Op. Income 3Y — — — — — — — — — 98.9% 48.0% 29.3% 7.8% -2.3% -7.8% -11.1% -3.9% -4.5% 3.9% 4.2% 4.17%
Op. Income 5Y — — — — — — — — — — — — — — — — — 46.3% 29.7% 19.0% 18.96%
FCF 3Y — — — — — — — — — 19.8% -14.9% -25.7% -32.3% -20.9% -11.7% -3.4% 4.0% -0.6% -5.9% 12.7% 12.70%
FCF 5Y — — — — — — — — — — — — — — — — — 27.2% 6.8% 5.8% 5.77%
OCF 3Y — — — — — — — — — 14.2% -22.3% -32.2% -38.2% -26.2% -17.0% -9.1% -2.2% -2.7% -3.2% 20.2% 20.20%
OCF 5Y — — — — — — — — — — — — — — — — — 26.8% 9.2% 9.7% 9.67%
Assets 3Y — — — — — — — — — 18.8% 18.8% 17.2% 16.0% 15.2% 15.2% 14.7% 14.7% 18.3% 18.3% 45.5% 45.55%
Assets 5Y — — — — — — — — — — — — — — — — — 20.9% 20.9% 33.4% 33.40%
Equity 3Y — — — — — — — — — 27.1% 27.1% 24.2% 25.2% 20.2% 20.2% 13.4% 13.4% 3.6% 3.6% 36.1% 36.08%
Book Value 3Y — — — — — — — — — 27.1% 27.1% 24.2% 25.2% 20.2% 20.2% 13.3% 13.1% 2.3% -9.7% 35.9% 35.87%
Dividend 3Y — — — — — — — — — -17.0% — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — 0.94 0.98 0.98 0.95 0.83 0.84 0.82 0.48 0.04 0.02 0.07 0.46 0.51 0.52 0.56 0.563
Earnings Stability — — — — — 0.92 0.94 0.87 0.07 0.69 0.71 0.73 0.00 0.28 0.06 0.00 0.35 0.09 0.00 0.05 0.054
Margin Stability — — — — — 0.99 0.98 0.98 0.96 0.99 0.98 0.98 0.96 0.96 0.88 0.93 0.97 0.94 0.84 0.88 0.878
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — 0.90 0.91 0.97 0.94 0.96 0.97 1.00 0.99 0.89 0.83 0.82 0.90 0.96 0.97 0.99 0.992
Earnings Smoothness — 0.00 0.22 0.50 0.77 0.78 0.81 0.92 0.84 0.90 0.93 1.00 0.98 0.69 0.45 0.44 0.72 0.89 0.94 0.98 0.980
ROE Trend — — — — — 0.10 0.04 0.02 -0.09 -0.06 -0.06 -0.07 -0.10 -0.12 -0.15 -0.13 -0.08 -0.03 -0.03 -0.11 -0.108
Gross Margin Trend — — — — — 0.00 0.00 0.00 -0.00 -0.01 0.00 0.03 0.03 -0.04 -0.13 -0.08 0.01 0.07 0.19 0.15 0.154
FCF Margin Trend — — — — — -0.20 -0.15 -0.16 -0.15 -0.16 -0.17 -0.14 -0.10 -0.01 0.08 0.15 0.18 0.10 0.00 0.00 0.003
Sustainable Growth Rate 27.4% 29.5% 32.1% 30.5% 35.5% 30.2% 29.0% 26.2% 22.9% 23.7% 26.0% 25.1% 21.3% 15.9% 12.7% 12.4% 14.1% 14.3% 13.7% 8.6% 8.60%
Internal Growth Rate 26.6% 29.1% 32.5% 31.9% 39.2% 32.9% 31.2% 27.5% 23.3% 25.5% 28.8% 28.2% 23.8% 16.6% 12.9% 11.7% 13.9% 11.3% 10.7% 6.5% 6.54%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.18 1.13 1.06 0.98 0.86 0.82 0.78 0.66 0.56 0.38 0.23 0.23 0.27 0.55 0.95 1.21 1.28 1.27 1.26 2.00 1.997
FCF/OCF 0.76 0.75 0.74 0.72 0.71 0.72 0.74 0.77 0.82 0.88 1.00 1.00 1.00 0.92 0.89 0.87 0.86 0.77 0.68 0.64 0.635
FCF/Net Income snapshot only 1.268
OCF/EBITDA snapshot only 1.152
CapEx/Revenue 10.9% 10.4% 10.5% 10.1% 9.3% 7.9% 6.8% 4.9% 2.9% 1.4% 0.0% 0.0% 0.0% 1.2% 2.8% 4.0% 4.9% 6.5% 6.8% 10.0% 9.95%
CapEx/Depreciation snapshot only 1.886
Accruals Ratio -0.05 -0.03 -0.02 0.00 0.04 0.05 0.06 0.08 0.10 0.14 0.17 0.17 0.14 0.06 0.01 -0.02 -0.03 -0.03 -0.03 -0.06 -0.061
Sloan Accruals snapshot only 0.047
Cash Flow Adequacy snapshot only 2.741
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.7% 0.5% 0.4% 0.3% 0.2% 0.3% 0.5% 0.5% 0.4% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $3.01 $2.51 $2.01 $1.50 $1.00 $1.75 $2.50 $2.25 $2.00 $1.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 21.7% 17.6% 13.6% 9.6% 5.7% 9.8% 13.9% 13.3% 13.4% 6.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 24.2% 20.9% 17.3% 13.5% 9.3% 16.6% 24.1% 26.1% 28.9% 18.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 21.7% 17.6% 13.6% 9.6% 5.7% 9.8% 13.9% 13.3% 13.4% 6.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak 0 1 1 0 0 0 1 0 0 0 — — — — — — — — — — —
Chowder Number — 2.34 0.34 -0.33 -0.67 -0.30 0.25 0.50 1.00 -0.43 — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.7% 0.5% 0.4% 0.3% 0.2% 0.3% 0.5% 0.5% 0.4% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.78 0.77 0.78 0.77 0.73 0.68 0.67 0.67 0.68 0.73 0.74 0.74 0.74 0.74 0.74 0.76 0.77 0.78 0.79 0.81 0.805
Interest Burden (EBT/EBIT) 0.98 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 1.04 1.04 1.07 1.01 0.94 0.92 0.922
EBIT Margin 0.51 0.48 0.49 0.49 0.52 0.52 0.50 0.49 0.43 0.42 0.43 0.45 0.43 0.39 0.33 0.32 0.32 0.29 0.23 0.18 0.184
Asset Turnover 0.69 0.74 0.76 0.72 0.80 0.78 0.83 0.77 0.75 0.71 0.71 0.66 0.60 0.50 0.44 0.42 0.46 0.45 0.57 0.45 0.449
Equity Multiplier 1.31 1.31 1.31 1.26 1.26 1.22 1.22 1.21 1.21 1.16 1.16 1.14 1.11 1.11 1.11 1.18 1.15 1.41 1.41 1.40 1.400
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $13.87 $14.22 $14.77 $15.67 $17.50 $17.82 $17.90 $16.94 $14.89 $16.16 $16.67 $16.96 $14.57 $11.80 $9.46 $9.51 $10.87 $10.13 $6.64 $9.69 $9.69
Book Value/Share $39.64 $46.35 $46.41 $53.33 $53.34 $59.98 $59.93 $59.03 $59.04 $68.16 $68.16 $76.03 $77.83 $80.56 $80.65 $77.46 $77.10 $64.21 $44.08 $148.06 $80.56
Tangible Book/Share $39.54 $46.25 $46.31 $53.23 $53.25 $59.89 $59.84 $56.59 $56.60 $65.72 $65.72 $73.59 $75.40 $78.12 $78.21 $66.83 $66.52 $37.00 $25.40 $95.16 $95.16
Revenue/Share $35.66 $38.46 $39.52 $42.00 $46.59 $50.66 $53.56 $52.72 $51.24 $52.65 $53.00 $51.14 $45.87 $41.30 $36.75 $37.64 $40.86 $45.33 $39.39 $70.91 $41.30
FCF/Share $12.42 $11.99 $11.58 $11.14 $10.71 $10.53 $10.35 $8.63 $6.91 $5.35 $3.83 $3.82 $3.86 $5.93 $7.97 $10.01 $11.95 $9.96 $5.70 $12.29 $12.05
OCF/Share $16.33 $16.01 $15.71 $15.38 $15.07 $14.54 $14.00 $11.19 $8.39 $6.09 $3.83 $3.82 $3.86 $6.44 $8.99 $11.53 $13.97 $12.90 $8.40 $19.34 $14.08
Cash/Share $3.44 $7.37 $7.38 $9.01 $9.01 $20.65 $20.63 $16.19 $16.20 $19.14 $19.14 $28.04 $29.60 $32.26 $32.29 $26.35 $26.23 $10.99 $7.55 $15.75 $32.26
EBITDA/Share $18.06 $17.92 $18.05 $19.14 $23.38 $26.39 $27.99 $27.39 $23.82 $24.08 $24.69 $24.97 $21.82 $18.28 $14.46 $14.41 $15.54 $15.32 $10.68 $16.79 $16.79
Debt/Share $6.03 $5.61 $5.62 $5.13 $5.14 $3.81 $3.81 $3.59 $3.59 $2.76 $2.76 $2.00 $1.36 $2.55 $2.56 $1.55 $1.54 $10.56 $7.25 $17.62 $17.62
Net Debt/Share $2.59 $-1.76 $-1.76 $-3.88 $-3.88 $-16.84 $-16.82 $-12.60 $-12.60 $-16.38 $-16.38 $-26.05 $-28.24 $-29.70 $-29.74 $-24.81 $-24.69 $-0.43 $-0.29 $1.87 $1.87
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 10.269
Altman Z-Prime snapshot only 18.430
Piotroski F-Score 4 7 7 7 7 8 7 6 5 6 6 6 5 5 5 5 5 4 5 4 4
Beneish M-Score — -2.37 -2.53 -1.95 -1.74 -1.80 -1.65 -2.54 -2.51 -2.07 -2.09 -1.54 -1.55 -1.42 -1.83 -2.35 -2.09 -1.31 -0.77 -0.55 -0.550
Ohlson O-Score snapshot only -10.558
ROIC (Greenblatt) snapshot only 10.02%
Net-Net WC snapshot only $7.87
EVA snapshot only $1006534003.34
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 95.59 95.39 95.76 95.61 95.53 95.45 95.83 95.64 96.20 95.56 95.53 95.34 95.06 95.24 95.36 94.99 95.19 94.83 94.80 91.29 91.292
Credit Grade snapshot only 2
Credit Trend snapshot only -3.700
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 80
Sector Credit Rank snapshot only 86

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms